Patents
Patents for C07K - Peptides (3,738)
11/1999
11/25/1999CA2327314A1 Soluble t cell receptor
11/23/1999US5990383 Plant transformed with nucleotide sequence which encodes a vegetative insecticidal protein from bacillus species
11/17/1999EP0957165A2 Optimizing cells for endogenous gene activation
11/16/1999US5985265 Attaching a polyethylene glycol molecule to a consensus interferon molecule via reductive alkylation.
11/16/1999CA2056402C Therapeutic agent
11/09/1999US5981589 Copolymer-1 improvements in compositions of copolymers
11/02/1999US5977071 Complexes; antidiabetic agent
10/1999
10/27/1999CN1233255A Preparation of purified (poly) peptides
10/13/1999EP0948349A1 Treatment of inner ear hair cells
10/12/1999US5965692 Anticoagulants for treatment of thromobosis and hypercoagulability in blood and tissues
10/12/1999US5965359 Mixing cells from biological sample with detectable labeled complementary dna probe, detecting the presence of the probe that hybridizes with messenger rna for human platelet-derived growth factor receptor gene
10/05/1999US5962331 Cell growth regulator
10/05/1999US5961977 Orally administering an autoantigen
09/1999
09/21/1999US5955425 Parathyroid hormone analogues for the treatment of osteoporosis
09/15/1999EP0941329A1 Methods for preventing graft rejection in transplantation and for producing a universal gene therapy host cell using lymphocyte activation (lag-3)
09/15/1999EP0941243A1 Polypeptides comprising gax protein domains, involved in repressing transcription and/or interacting with other proteins, corresponding nucleic acids and their use
09/14/1999US5952300 Antifungal compositions
09/01/1999EP0938500A1 INTERLEUKIN-1beta-CONVERTING ENZYME (ICE) INHIBITING PEPTIDES
09/01/1999CN1227604A Multivarient IL-3 hematopoiesis fusion protein
08/1999
08/25/1999EP0646016B1 Synthetic peptides for the treatment of myasthenia gravis
08/17/1999US5939391 Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation
08/10/1999US5936089 Dipeptides which promote release of growth hormone
08/10/1999US5935795 Glial cell line-derived neurotrophic factor antibody
08/05/1999WO1999038973A2 Compounds for therapy and diagnosis of lung cancer and methods for their use
08/05/1999CA2319117A1 Compounds for therapy and diagnosis of lung cancer and methods for their use
08/04/1999EP0932681A2 Compounds and methods for immunotherapy and diagnosis of tuberculosis
07/1999
07/20/1999US5925347 Viral vector vaccines comprising nucleic acids encoding eimeria proteins for poultry vaccination against coccidiosis
07/14/1999CN1222917A Novel protein and process for producing the same
06/1999
06/30/1999EP0756602B1 Cck or gastrin modulating 5-heterocyclic-1,5-benzodiazepines
06/30/1999EP0748337B1 Process for the obtention of a biological adhesive comprising fibrinogen, factor xiii and fibronectin
06/24/1999WO1999020654A3 NOVEL HUMAN β2 INTEGRIN ALPHA SUBUNIT
06/17/1999WO1998018823A8 Ice inhibiting peptides
06/16/1999EP0921815A1 Therapeutic uses of humanized antibodies against alpha-4 integrin
06/15/1999US5912226 Antibiotic
06/09/1999EP0920448A1 Truncated glial cell line-derived neurotrophic factor
06/02/1999EP0919619A2 Optimizing cells for endogenous gene activation
06/02/1999EP0918540A1 Intradermal bovine polynucleotide vaccine
06/01/1999US5908839 Administering mixture of tyrosine kinase inhibitor and amino sterol
05/1999
05/26/1999EP0859785A4 Cyclic peptide analogs of somatostatin
05/25/1999US5907043 Coupling n-(4-methoxybenzoyl)-l-valyl-l-proline or a salt with 3-amino-4-methyl-1,1,1-trifluoro-2-pentanol forming (s)-1-(s)-2-(4-methoxybenzamido)-3-(2,2,2-trifluoro-1-hydroxy ethyl)propyl)pyrrolidine-2-carboxamide, oxidizing the product
05/25/1999US5906922 Delivery of nucleic acids
05/19/1999CN1217022A Therapeutic uses of keratinocyte growth factor
05/12/1999EP0733067B1 N-terminally chemically modified protein compositions and methods
05/12/1999CN1216549A Antipathogenic peptides and compositions comprising them
05/06/1999WO1999021888A1 Aggregates of human insulin derivatives
05/06/1999CA2308705A1 Aggregates of human insulin derivatives
05/05/1999CN1216063A IL-6 mutein
04/1999
04/29/1999WO1999021014A1 Determination of cellular growth abnormality
04/29/1999WO1999020654A2 NOVEL HUMAN β2 INTEGRIN ALPHA SUBUNIT
04/29/1999CA2273193A1 Novel human .beta.2 integrin alpha subunit
04/28/1999EP0911342A1 Novel protein and process for producing the same
04/28/1999EP0456766B1 TYPE oc PLATELET-DERIVED GROWTH FACTOR RECEPTOR GENE
04/27/1999US5897862 Immuno-stimulatory monoclonal antibodies
04/22/1999WO1998045328A3 Compositions and methods for the treatment and diagnosis of breast cancer
04/14/1999EP0907737A1 Il-6 mutein
03/1999
03/31/1999EP0904291A2 Antipathogenic peptides and compositions comprising them
03/30/1999US5889174 Nucleotide sequences encoding pesticidal proteins
03/30/1999US5888801 Bacillus thuringiensis
03/23/1999US5885575 Diagnosis and therapy of tumour metastases
03/10/1999EP0900231A1 Flea protease proteins, nucleic acid molecules, and uses thereof
03/10/1999CN1210558A Recombinant phages
02/1999
02/25/1999WO1999009063A1 Interleukin-18 binding proteins, their preparation and use
02/25/1999CA2298855A1 Interleukin-18 binding proteins, their preparation and use
02/24/1999CN1209139A Prodrugs of thrombin inhibitors
02/23/1999US5874228 Methods and kits for determining the levels of IGE-BF
02/16/1999US5872212 Pesticidal proteins and strains
02/10/1999EP0659174B1 Derivatives of valproic and 2-valproenoic acid amides and use as anticonvulsants
02/09/1999CA2226091C Cyclosporin-containing soft capsule preparations
02/03/1999CN1207044A Cyclosporin-containing soft capsule preparations
02/03/1999CN1041919C N-(3-piperidinylcarbonyl)-beta-alanine derivatives as PAF antagonists
02/02/1999US5866326 Hybrids
01/1999
01/13/1999EP0889955A1 Recombinant phages
01/12/1999US5858368 Vaccine comprising a baculovirus produced influenza hemagglutinin protein fused to a second protein
01/05/1999US5856124 DNA encoding high-affinity melatonin receptors
12/1998
12/30/1998WO1998058646A1 Use of somatostatin agonists and antagonists for treating diseases related to the eye
12/15/1998US5849870 Pesticidal proteins and strains
12/15/1998US5849860 Polyethylene-protein conjugates
12/10/1998WO1998055624A1 Bacterial pheromones and uses therefor
12/02/1998EP0743953B1 Diastereomeric pure trifluoromethyl ketone peptide derivatives as inhibitors of human leukocyte elastase
12/01/1998US5844089 Genetically fused globin-like polypeptides having hemoglobin-like activity
12/01/1998US5844088 Hemoglobin-like protein comprising genetically fused globin-like polypeptides
12/01/1998US5843676 Purified immunoglobulin-related factor, novel monoclonal antibodies, hybridoma cell lines, processes and applications
12/01/1998US5843448 Tumor rejection antigen precursor
11/1998
11/25/1998EP0695189B1 Treatment of inflammatory bowel disease with ifn-gamma inhibitors
11/24/1998US5840868 Pesticidal proteins and strains
11/24/1998US5840525 P185 receptor implicated in cellular growth
11/24/1998US5840299 Binding and treatment of multiple sclerosis
11/17/1998US5837478 Cellular adhesion molecules
11/10/1998US5834594 Polyethylene-protein conjugates
10/1998
10/28/1998EP0605484B1 Peptides having growth hormone releasing activity
10/28/1998CN1197461A Truncated glial cell line-derived neurotrophic factor
10/28/1998CN1197460A Cyclic peptide analogs of somatostatin
10/22/1998WO1998046644A1 Novel protein and process for producing the same
10/22/1998CA2781623A1 Novel protein binding to osteoclastogenesis inhibitory factor and process for producing the same
10/20/1998US5824784 Genetic engineering with polypeptides and proteins
10/15/1998WO1998045328A2 Compositions and methods for the treatment and diagnosis of breast cancer
10/15/1998CA2286348A1 Compositions and methods for the treatment and diagnosis of breast cancer
10/14/1998EP0869966A1 Prodrugs of thrombin inhibitors
10/14/1998EP0869810A1 Cyclosporin-containing soft capsule preparations
10/08/1998WO1998016646A3 Compounds and methods for immunotherapy and diagnosis of tuberculosis
1 ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38